Featured Press Releases

Theralogix Introduces Berberine Enhanced Absorption

Theralogix Introduces Berberine Enhanced Absorption

Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study

Biolexis Therapeutics reports positive outcomes for BLX-7006 in an expanded Diet-Induced Obesity (DIO) model study

  • 09 Dec 2024

Biolexis Therapeutics, a leading metabolic drug discovery company focused on improving the lives...

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

Baird Medical’s MWA system has achieved successful Medicare reimbursement at a prominent New York practice

30% Lower Risk With WELIREG® + LENVIMA® vs. Cabozantinib in Previously Treated RCC

30% Lower Risk With WELIREG® + LENVIMA® vs. Cabozantinib in Previously Treated RCC

Apertura Gene Therapy and Broad Institute scientists share data on TfR1 CapX™, a novel CNS-targeting capsid

Apertura Gene Therapy and Broad Institute scientists share data on TfR1 CapX™, a novel CNS-targeting capsid

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

Beauty Crush Skincare Introduces a New Standard in Regenerative Biotech Skincare

  • Beauty Crush Skincare
  • 04 Jun 2026
Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

Brain Navi’s KrystoLens Receives TFDA Certification and Is Set to Enter the Taiwan Market

  • Brain Navi Biotechnology
  • 04 Jun 2026
SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

SK bioscience Improves Vaccine Access by Securing Its First UNICEF Procurement Contract

  • SK bioscience
  • 03 Jun 2026
ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience

ChromaDex Renames Its External Research Program to the Niagen Research Program, Strengthening Niagen Bioscience's Position as the Global Leader in NAD+ Science

  • Niagen Bioscience, Inc
  • 03 Jun 2026
AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

AddiVance Offers a Drug-Free Option for Daily Focus, Attention, and Cognitive Support for Families

  • Medella Springs
  • 02 Jun 2026
Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

Seegene Expands Its AMR Testing Portfolio in Europe with the Launch of the Allplex™ MDRO Assay Under IVDR

  • Seegene
  • 02 Jun 2026
The Digital Pharma Advances Conference 2026

Most Popular
June   2026
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.